The 15th Bergmeyer Conference.

Ian S Young, Philippe Gillery
{"title":"The 15th Bergmeyer Conference.","authors":"Ian S Young, Philippe Gillery","doi":"10.1080/00365513.2016.1206432","DOIUrl":null,"url":null,"abstract":"The Scientific Division of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) is committed to promoting high standards and laboratory medicine on an international basis and disseminating the results of emerging research to ensure early adoption of good practice for the benefit of patients. To further these objectives, the division organizes Bergmeyer Conferences on a two-yearly basis. Conferences are devoted to a key topic of current interest in laboratory medicine, and provide a forum for invited experts to share recent innovation and emerging findings and to discuss areas of controversy and highlight future needs. The Bergmeyer conferences are dedicated to the memory of Prof Hans-Ulrich Bergmeyer [1] and honour his outstanding achievements in biochemistry and the area of standardization. The series began 28 years ago and is still generously fully sponsored by Roche Diagnostics, although the programme is selected entirely independently by the IFCC. The previous Bergmeyer conferences are shown in Table 1. The 15th Bergmeyer conference (7–9 March 2016) was entitled ‘Biomarkers in the Diagnosis and Monitoring of Cancer’ and was focused on the impact of new and emerging technologies and the potential which they offer to improve patient care. Speakers addressed both specific cancers and specific technologies and biomarkers, as well as discussing some of the broader economic and ethical challenges which are emerging in the era of personalized cancer care. As in previous years, a distinguished multidisciplinary panel of speakers was joined by an invited audience of laboratory professionals who contributed to the high-level discussion which characterizes the Bergmeyer conference. With a small number of exceptions, articles based on the presentations given at the conference are presented in this issue. They provide a strong overview of key issues in the field and will hopefully provide both a useful resource and a useful summary of the current state of knowledge in this important area. As for all the previous Conferences, Anders Kallner again took over the main responsibility of editing these proceedings, and is joined by Joseph Lopez and Leslie Lai who also helped to put discussions in their proper context. Paola Bramati at the IFCC office supported the organization of the scientific aspects of the Conference. Last but not least, Joe Passarelli and his staff carried the burden of organizing the Conference in Eibsee, Germany, and in achieving, once again, an outstanding meeting.","PeriodicalId":76518,"journal":{"name":"Scandinavian journal of clinical and laboratory investigation. Supplementum","volume":"245 ","pages":"S1"},"PeriodicalIF":0.0000,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/00365513.2016.1206432","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scandinavian journal of clinical and laboratory investigation. Supplementum","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/00365513.2016.1206432","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2016/7/19 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The Scientific Division of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) is committed to promoting high standards and laboratory medicine on an international basis and disseminating the results of emerging research to ensure early adoption of good practice for the benefit of patients. To further these objectives, the division organizes Bergmeyer Conferences on a two-yearly basis. Conferences are devoted to a key topic of current interest in laboratory medicine, and provide a forum for invited experts to share recent innovation and emerging findings and to discuss areas of controversy and highlight future needs. The Bergmeyer conferences are dedicated to the memory of Prof Hans-Ulrich Bergmeyer [1] and honour his outstanding achievements in biochemistry and the area of standardization. The series began 28 years ago and is still generously fully sponsored by Roche Diagnostics, although the programme is selected entirely independently by the IFCC. The previous Bergmeyer conferences are shown in Table 1. The 15th Bergmeyer conference (7–9 March 2016) was entitled ‘Biomarkers in the Diagnosis and Monitoring of Cancer’ and was focused on the impact of new and emerging technologies and the potential which they offer to improve patient care. Speakers addressed both specific cancers and specific technologies and biomarkers, as well as discussing some of the broader economic and ethical challenges which are emerging in the era of personalized cancer care. As in previous years, a distinguished multidisciplinary panel of speakers was joined by an invited audience of laboratory professionals who contributed to the high-level discussion which characterizes the Bergmeyer conference. With a small number of exceptions, articles based on the presentations given at the conference are presented in this issue. They provide a strong overview of key issues in the field and will hopefully provide both a useful resource and a useful summary of the current state of knowledge in this important area. As for all the previous Conferences, Anders Kallner again took over the main responsibility of editing these proceedings, and is joined by Joseph Lopez and Leslie Lai who also helped to put discussions in their proper context. Paola Bramati at the IFCC office supported the organization of the scientific aspects of the Conference. Last but not least, Joe Passarelli and his staff carried the burden of organizing the Conference in Eibsee, Germany, and in achieving, once again, an outstanding meeting.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
第15届伯格迈耶会议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Highlight on DPYD gene polymorphisms and treatment by capecitabine (.). Serum thyroglobulin in the monitoring of differentiated thyroid cancer. Precision medicine: what's all the fuss about? Biomarkers along the continuum of care in lung cancer. microRNAs as cancer biomarkers.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1